AEGLE THERAPEUTICS

In News

The Emerging Role of Exosome Therapeutics in 2026 - BioInformant

BioInformant - Oct 27, 2025

Aegle Therapeutics Names Scott Braunstein, M.D. as Chairman of the Board - citybiz

citybiz - Jul 15, 2025

Aegle Therapeutics Corp. Announces Positive Data for the First Patient in a Phase 1/2a Clinical Trial Dosed With AGLE-102™, a Novel Extracellular Vesicle Therapy - PR Newswire

PR Newswire - Jan 08, 2024

Clinical Trial Update: First Patient Dosed in Phase 1/2a Trial of AGLE-102 in DEB - The Dermatology Digest

The Dermatology Digest - Aug 14, 2024

Miami biotech startup Aegle Therapeutics draws $4M investment round - Refresh Miami

Refresh Miami - Jan 08, 2020

Six exosome therapy companies driving development in the field - Labiotech.eu

Labiotech.eu - Nov 14, 2024

Aegle Therapeutics Prepares Phase 1/2a Trial of BM-MSC Derived Extracellular Vesicles - BioInformant

BioInformant - Jul 20, 2018

Therapeutic effect of Aegle marmelos fruit extract against DMBA induced breast cancer in rats - Nature

Nature - Oct 22, 2020

Epidermolysis Bullosa Market Set for Significant Upswing During the Forecast Period (2025-2034) Amid Rising Therapeutic Advancements | DelveInsight - PR Newswire

PR Newswire - Mar 17, 2026

Designer Exosomes: The Future of Targeted Therapy and Regenerative Medicine - BioInformant

BioInformant - Apr 09, 2025

Exosome Therapies on the Rise as 70+ Major Companies Driving Development in the Field | DelveInsight - PR Newswire

PR Newswire - Nov 04, 2024

Funding Flows Freely into Exosome Therapeutics in 2025 - BioInformant

BioInformant - Jan 04, 2025

Stay Informed

Join our mailing list for the latest report releases and upcoming event notifications.

Headquartered in Boston, Mass., for over 50 years, BCC Research takes pride in being your trusted custom research and data analysts. Our mission is to provide businesses with reputable data and market research reports, so that they gain new perspectives into their field and better understand their target audience. We enable companies to access reliable information, accurate forecasts, and actionable insights, so that they may become leaders in their industry.

AI Sentiment